The risk for embryonal tumors in BWS results primarily from dysregulation at the telomeric domain of 11p15 (gain of methylation at ICR1 and UPD) rather than at the centromeric domain (loss of methylation at ICR2 and pathogenic variants in CDKN1C) (19, 20). This evidence concerns the gene CDKN1C and embryonal neoplasm.